Degree of Discordance Between FIB-4 and Transient Elastography: An Application of Current Guidelines on General Population Cohort
Clinical Gastroenterology and Hepatology · 2024-07 · 22 (7) · 1453-1461.e2
DOI: 10.1016/j.cgh.2024.02.008 ↗Kurz gefasst
Leitlinie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024-07. Verfasst von Madeleine Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Arnold O. Beckman High School, Irvine, California. Hauptthemen laut MEDLINE: Elasticity Imaging Techniques, Liver Cirrhosis. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND & AIMS: In the American Gastroenterological Association/American Association for the Study of Liver Diseases (AGA/AASLD) Clinical Care Pathway, Fibrosis-4 index (FIB-4) is used to stratify patients at risk for metabolic dysfunction-associated steatotic liver disease (MASLD) as low-, indeterminate-, or high-risk for developing advanced liver fibrosis. We assessed the performance of FIB-4 in a general population. METHODS: Using the 2017 to 2020 National Health and Nutrition Examination Surveys dataset, we selected subjects ≥18 years who had FibroScan data. We followed AGA/AASLD guidelines to identify subjects with characteristics that place them at risk for MASLD-associated liver fibrosis. Other causes of liver disease were excluded. Our final cohort had 3741 subjects. We then categorized these subjects based on recommended FIB-4 cutoffs. FibroScan liver stiffness measurement (LSM) served as the outcome measurement. RESULTS: Among the 2776 subjects (74.2%) classified as low risk by FIB-4, 277 subjects (10%) were not classified at low risk by LSM, and 75 subjects (2.7%) were classified as high risk by LSM. Among the 86 subjects classified as high risk by FIB-4, 68 subjects (79.1%) were not at high risk by LSM, and 54 subjects (62.8%) were at low risk by LSM. Subjects misclassified by FIB-4 as low risk were older; had a higher body mass index, waist circumference, glycohemoglobin A1c level, alanine transaminase, aspartate transaminase, diastolic blood pressure, controlled attenuation parameter score, white blood cell count, alkaline phosphatase, and fasting glucose level; but had lower high-density lipoprotein, and albumin level (all P < .05). Misclassified subjects were also more likely to have prediabetes/diabetes. CONCLUSION: Using FIB-4 in the AGA/AASLD guidelines to risk-stratify subjects at risk for MASLD-associated fibrosis results in many subjects being misclassified into the low- and high-risk categories. Therefore, it may be worthwhile considering caution in interpretation and/or alternative strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Arnold O. Beckman High School, Irvine, California.
- Houston Methodist, Houston, Texas.
- Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom; Pinnacle Research Center, San Antonio, Texas.
- Arizona Liver Health, Phoenix, Arizona.
- Houston Methodist, Houston, Texas. Electronic address: noureddinmd@houstonresearchinstitute.com.
Zitieren
APA
Chang, M., Chang, D., Kodali, S., Harrison, S. A., Ghobrial, M., Alkhouri, N., & Noureddin, M. (2024). Degree of Discordance Between FIB-4 and Transient Elastography: An Application of Current Guidelines on General Population Cohort. Clinical Gastroenterology and Hepatology, 22(7), 1453-1461.e2. https://doi.org/10.1016/j.cgh.2024.02.008
Vancouver
Chang M, Chang D, Kodali S, Harrison SA, Ghobrial M, Alkhouri N, et al. Degree of Discordance Between FIB-4 and Transient Elastography: An Application of Current Guidelines on General Population Cohort. Clinical Gastroenterology and Hepatology. 2024;22(7):1453-1461.e2. doi:10.1016/j.cgh.2024.02.008
BibTeX
@article{Chang2024,
author = {Chang, Madeleine and Chang, Devon and Kodali, Sudha and Harrison, Stephen A and Ghobrial, Mark and Alkhouri, Naim and Noureddin, Mazen},
title = {Degree of Discordance Between FIB-4 and Transient Elastography: An Application of Current Guidelines on General Population Cohort},
journal = {Clinical Gastroenterology and Hepatology},
year = {2024},
volume = {22},
number = {7},
pages = {1453--1461.e2},
doi = {10.1016/j.cgh.2024.02.008}
}
EUVIMED